20 November 2025 – In the frame of the ICPerMed Strategic Working Group on Internationalisation, a webinar was organised on 20 November 2025 from 15:00-16:30 CET. Dr. Emmanouil (Manolis) Dermitzakis introduced the Qatar Precision Health Institute.
Dr. Emmanouil (Manolis) Dermitzakis (Qatar)
Dr. Dermitzakis is the President of the Qatar Precision Health Institute. He is also co-founder and the CEO of Antithesis Therapeutics. Previously, he was Vice President and Head of Computational Biology at GSK as well as Professor of Genetics in the Department of Genetic Medicine and Development, University of Geneva Medical School.
This is the third event of a series of webinars with the aim to overall increase the awareness about Personalised Medicine and to share information about activities and successes in the field.